CSIMarket Company Name, Ticker, Customers, else..
 

U s Stem Cell Inc   (NONE: USRM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

U S Stem Cell Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

USRM Sales vs. its Competitors Q4 2022


Comparing the current results to its competitors, U S Stem Cell Inc reported Revenue decrease in the 4 quarter 2022 year on year by -15.34 %, despite the revenue increase by the most of its competitors of 22.38 %, recorded in the same quarter.

• List of USRM Competitors





Revenue Growth Comparisons




Net Income Comparison

U s Stem Cell Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  USRM Stock Performance Comparisons





  

Overall company Market Share Q4 2022
Overall company, revenue fell by -15.34 % company lost market share within this segment.




<<  More on USRM Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of U s Stem Cell Inc




Mangoceuticals Inc
Share Performance



-2.43%
Over The Past 5 Days
Mangoceuticals Inc
Profile

Mangoceuticals Inc's business model focuses on producing and selling products that harness the beneficial properties of mangoes, potentially in the field of skincare or healthcare.

More about Mangoceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6.682 mill. $ 0.315 mill. $ -15.104 mill.

Sources: U s Stem Cell Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on U s Stem Cell Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.